FiercePharma6d
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose
Ten years after dipping its toes into the gene therapy pool in a licensing deal with Spark Therapeutics, Pfizer has gained FDA approval for the acquired treatment. The U.S. regulator has endorsed ...
Yahoo6d
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The ...
Yahoo Finance7d
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
By Blake Brittain (Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in ...
Seeking Alpha6d
Pfizer gets FDA approval for hemophilia B gene therapy Beqvez
Pfizer (NYSE:PFE) said it has received FDA approval for its one-time gene therapy Beqvez for the treatment of certain adults with hemophilia B. The drugmaker said the therapy is aimed at enabling ...
Forbes6d
What Factors Will Drive Pfizer's Q1 Performance?
Pfizer (NYSE: PFE) is scheduled to report its Q1 2024 results on Wednesday, May 1. We expect the company to post revenue of $13.8 billion and earnings of $0.50 on a per share and adjusted basis ...
FiercePharma6d
GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech are being dragged into another round of mRNA litigation by GSK.
Yahoo Finance7d
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the ...
MedCity News7d
Pfizer’s First Gene Therapy Approval Sets Up a Showdown With CSL in Hemophilia B
Pfizer’s first FDA-approved gene therapy is the second such treatment for the inherited bleeding disorder hemophilia B, introducing some competition to a therapeutic area that now has two of the ...
Benzinga.com6d
Pfizer's Options: A Look at What the Big Money is Thinking
Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...
Reuters6d
US FDA approves Pfizer's gene therapy for rare bleeding disorder
It predominately affects males. Pfizer's one-time therapy, branded as Beqvez, is designed to stimulate production of the protein, called factor IX (FIX), by the patient's own body instead of ...
NBC Chicago7d
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
The Food and Drug Administration approved Pfizer's treatment for a rare genetic bleeding disorder, making it the company's first-ever gene therapy to win clearance in the U.S. The agency ...
NBC DFW7d
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
The Food and Drug Administration approved Pfizer's treatment for a rare genetic bleeding disorder, making it the company's first-ever gene therapy to win clearance in the U.S. The agency ...